42
Participants
Start Date
July 2, 2020
Primary Completion Date
November 26, 2020
Study Completion Date
December 23, 2020
Opaganib
Study participants received opaganib 2 x 250 mg capsules (500 mg) plus standard of care every 12 hours (pharmacological and/or supportive).
Placebo
Study participants received placebo 2 x 250 mg capsules (500 mg) plus standard of care every 12 hours (pharmacological and/or supportive).
Albany Medical Center, Albany
Miami Cancer Institute, Miami
Henry Ford Hospital, Detroit
Ascension St. John Hospital, Detroit
Memorial Herman Southeast Hospital, Houston
Memorial Hermann, Memorial City Medical Center, Houston
HonorHealth Research Institute, Scottsdale
Oregon Health & Science University, Portland
Ziv Medical Center, Safed
RedHill Biopharma Limited
INDUSTRY